Sale!
Tirzepatide 10mg 10vials

Tirzepatide 10mg 10vials

Original price was: $320.00.Current price is: $250.00.

Tirzepatide is a peptide that activates both GLP-1 and GIP receptors. It was developed to fight type 2 diabetes by lowering blood sugar levels, boosting insulin sensitivity, and reducing hunger. In addition to cardiovascular benefits, recent trials have demonstrated impressive results when used for weight loss.

  • Country of origin:
  • Package :10mg * 10vials *1kits (100mg/box) ,No water included.
  • Price: $15 — $30 per mg
  • Minimum Order:1 kits or 5 vials
  • Formula :C225H348N48O68
  • CAS No. : 2023788-19-2
  • Appearance:White Lyophilized Powder
  • Storage: refrigerator at 2??C to 8??C (36??F to 46??F) and avoid frozen.
  • Delivery: 100% delivery 5-15 days
  • Payment: W.U,T.T,Paypal,BTC,USDT

100% delivery

  • Done Satisfaction Guaranteed
  • Done No Hassle Refunds
  • Done Secure Payments
GUARANTEED SAFE CHECKOUT
  • Visa Card
  • MasterCard
Categories: , , Tags: ,

Description

What Is Tirzepatide?

Tirzepatide is an analog peptide to the glucose-dependent insulinotropic polypeptide (GIP). It is a novel peptide, Tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP),Gastric inhibitory peptide (GIP) is a hormone produced by the duodenum and small intestine. It acts as an incretin and stimulates the production of insulin. Unlike GIP, which is made of 42 amino acids, Tirzepatide has a modified amino acid chain consisting of 39 amino acids which are additionally lipidated to improve the peptide??s uptake into cells and its stability during metabolism.

Tirzepatide as a peptide hormone ,that has the potential to act as an agonist at both the gastric inhibitory polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. The action of Tirzepatide (GIP) peptide is apparently mediated through activation of the GLP-1 and GIP receptors, possibly leading to enhanced insulin secretion, glucose uptake, and satiety signaling.

Because tirzepatide is a synthetic derivative of gastric inhibitory polypeptide (GIP) that has simultaneous glucagon-like peptide-1 (GLP-1) functionality as well. This combination allows Tirzepatide to lower blood glucose levels, increase insulin sensitivity, boost feelings of satiety, and accelerate weight loss. Tirzepatide was developed to fight type 2 diabetes, but has additionally been shown to protect the cardiovascular system recent trials have demonstrated impressive results when used for weight loss.

Related products